Skip to main content
. 2020 Mar 11;45(4):262–270. doi: 10.1503/jpn.190060

Table 1.

Demographic and clinical characteristics*

Characteristic iTBS (n = 15) 5 Hz rTMS (n = 11) Sham (n = 15) p value
Age, yr 60.13 ± 14.1 57.45 ± 12.3 56.23 ± 12 0.77
M/F, n 11/4 9/2 13/2 0.65
Education, yr 11.27 ± 5.4 14 ± 2.8 13.64 ± 1.9 0.56
Poststroke duration, mo 18.47 ± 20.21 33.27 ± 26.4 38 ± 7.9 0.016
Ischemic stroke/hemorrhagic stroke, n 7/8 3/8 10/5 0.14
Lesion site (cortex + subcortical, or subcortical), n 11/4 10/1 12/3 0.31
Anomic aphasia, n 5 < 5 < 5 0.86
Comorbidities, n
 Hypertension 9 < 5 10 0.29
 Diabetes mellitus 5 < 5 < 5 0.23
 Dyslipidemia < 5 0 < 5 0.43
RBANS scores
 Total 73.7 ± 12.2 69.1 ± 10.9 65.3 ± 16.1 0.19
 Immediate memory 73.1 ± 16.6 69.2 ± 20.0 61.3 ± 20.0 0.25
 Visuospatial ability 98.9 ± 13.4 87.0 ± 13.9 82.9 ± 15.6 0.17
 Language 70.1 ± 14.0 76.3 ± 4.8 63.3 ± 18.1 0.25
 Attention 77.5 ± 19.1 70.1 ± 18.9 76.1 ± 20.8 0.52
 Delayed memory 79.5 ± 18.8 75.1 ± 21.1 76.1 ± 20.8 0.86
Beck Depression Inventory score 14.5 ± 10.0 13.0 ± 13.2 9.2 ± 8.2 0.27

F = female; iTBS = intermittent theta burst stimulation; M = male; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; rTMS = repetitive transcranial magnetic stimulation.

*

Data are mean ± standard deviation unless otherwise specified. Populations of fewer than 5 people have been rounded to protect participant privacy.

One-way analysis of variance for continuous data and a χ2 test, with significance levels set at p < 0.05. Post hoc analyses revealed significantly longer disease duration in the 5 Hz rTMS group at baseline (p = 0.016), which we used as an explanatory variable for intergroup comparison. Bonferroni correction: iTBS v. 5 Hz rTMS, Z = −3.776, p = 0.001.